Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Delayed Data from NYSE)

$11.02 USD

11.02
371,820

-0.05 (-0.45%)

Updated Aug 28, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (168 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Income Statements

Fiscal Year end for Pediatrix Medical Group, Inc falls in the month of December .

All items in Millions except EPS data.

12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Sales 1,995 1,972 1,911 1,734 3,514
Cost Of Goods 1,573 1,505 1,398 1,285 2,622
Gross Profit 422 467 513 449 892
Selling & Adminstrative & Depr. & Amort Expenses 414 294 310 351 2,028
Income After Depreciation & Amortization 7 173 203 98 -1,136
Non-Operating Income -14 -52 1 20 13
Interest Expense 42 40 69 110 119
Pretax Income -48 81 135 7 -1,242
Income Taxes 12 19 27 17 -92
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations -60 63 108 -10 -1,150
Extras & Discontinued Operations 0 4 23 -787 -348
Net Income (GAAP) -60 66 131 -796 -1,498
Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Income Before Depreciation & Amortization 45 210 239 134 398
Depreciation & Amortization (Cash Flow) 37 37 36 36 1,534
Income After Depreciation & Amortization 7 173 203 98 -1,136
Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Average Shares 82.20 84.12 85.83 83.40 83.50
Diluted EPS Before Non-Recurring Items 1.15 1.54 1.51 0.76 3.14
Diluted Net EPS (GAAP) -0.73 0.79 1.53 -9.55 -17.94

Fiscal Year end for Pediatrix Medical Group, Inc falls in the month of December .

All items in Millions except EPS data.

6/30/24 3/31/24 12/31/23 9/30/23 6/30/23
Sales 504.30 495.10 496.44 506.61 500.58
Cost Of Goods 390.18 400.22 395.28 399.72 385.12
Gross Profit 114.12 94.88 101.17 106.89 115.46
SG&A, R&D, and Dept/Amort Expenses 271.84 78.99 210.43 66.62 66.96
Income After SG&A, R&D, and Dept/Amort Expenses -157.72 15.89 -109.26 40.27 48.50
Non-Operating Income 0.30 2.53 2.72 0.93 1.68
Interest Expense 10.31 10.60 10.08 10.37 11.23
Pretax Income -167.73 7.82 -138.85 30.83 38.95
Income Taxes -14.70 3.79 -14.56 9.44 10.67
Minority Interest 0.00 0.00 0.00 0.00 0.00
Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
Other Income/Charges 0.00 0.00 0.00 0.00 0.00
Income From Cont. Operations -153.03 4.04 -124.29 21.39 28.28
Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Net Income (GAAP) -153.03 4.04 -124.29 21.39 28.28
Earnings Per Share Data 6/30/24 3/31/24 12/31/23 9/30/23 6/30/23
Average Shares 83.33 83.28 82.66 82.95 82.66
Diluted EPS Before Non-Recurring Items 0.32 0.17 0.29 0.29 0.37
Diluted Net EPS (GAAP) -1.84 0.05 -1.50 0.26 0.34